Literature DB >> 23552418

HIV-1 Vpu does not degrade interferon regulatory factor 3.

Dominik Hotter1, Frank Kirchhoff, Daniel Sauter.   

Abstract

It has been reported that HIV-1 Vpu mediates the degradation of interferon regulatory factor 3 (IRF-3) to avoid innate immune sensing. Here, we show that Vpu does not deplete IRF-3 from transfected cell lines or HIV-1-infected primary cells. Furthermore, the Vpu-dependent suppression of beta interferon expression described in previous studies could be ascribed to inhibition of NF-κB activation. Thus, Vpu suppresses innate immune activation through inhibition of NF-κB rather than degradation of IRF-3.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23552418      PMCID: PMC3676088          DOI: 10.1128/JVI.00526-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Zinc-binding domain of rotavirus NSP1 is required for proteasome-dependent degradation of IRF3 and autoregulatory NSP1 stability.

Authors:  Joel W Graff; Julie Ewen; Khalil Ettayebi; Michele E Hardy
Journal:  J Gen Virol       Date:  2007-02       Impact factor: 3.891

2.  Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection.

Authors:  Steffen Wildum; Michael Schindler; Jan Münch; Frank Kirchhoff
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

3.  The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.

Authors:  M E Greenberg; A J Iafrate; J Skowronski
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

4.  Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein.

Authors:  K Strebel; T Klimkait; F Maldarelli; M A Martin
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

5.  Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1.

Authors:  Michael Schindler; Jan Münch; Olaf Kutsch; Hui Li; Mario L Santiago; Frederic Bibollet-Ruche; Michaela C Müller-Trutwin; Francis J Novembre; Martine Peeters; Valerie Courgnaud; Elizabeth Bailes; Pierre Roques; Donald L Sodora; Guido Silvestri; Paul M Sharp; Beatrice H Hahn; Frank Kirchhoff
Journal:  Cell       Date:  2006-06-16       Impact factor: 41.582

6.  The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation.

Authors:  S Bour; U Schubert; K Strebel
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies.

Authors:  Ming Li; Feng Gao; John R Mascola; Leonidas Stamatatos; Victoria R Polonis; Marguerite Koutsoukos; Gerald Voss; Paul Goepfert; Peter Gilbert; Kelli M Greene; Miroslawa Bilska; Denise L Kothe; Jesus F Salazar-Gonzalez; Xiping Wei; Julie M Decker; Beatrice H Hahn; David C Montefiori
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

8.  Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3.

Authors:  Mario Barro; John T Patton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-01       Impact factor: 11.205

9.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

10.  Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses.

Authors:  H G Göttlinger; T Dorfman; E A Cohen; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

View more
  20 in total

1.  HIV Vpu Interferes with NF-κB Activity but Not with Interferon Regulatory Factor 3.

Authors:  Lara Manganaro; Elisa de Castro; Ana M Maestre; Kevin Olivieri; Adolfo García-Sastre; Ana Fernandez-Sesma; Viviana Simon
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

Review 2.  Innate immunity against HIV-1 infection.

Authors:  Marcus Altfeld; Michael Gale
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

3.  IFI16 Targets the Transcription Factor Sp1 to Suppress HIV-1 Transcription and Latency Reactivation.

Authors:  Dominik Hotter; Matteo Bosso; Kasper L Jønsson; Christian Krapp; Christina M Stürzel; Atze Das; Elisabeth Littwitz-Salomon; Ben Berkhout; Alina Russ; Sabine Wittmann; Thomas Gramberg; Yue Zheng; Laura J Martins; Vicente Planelles; Martin R Jakobsen; Beatrice H Hahn; Ulf Dittmer; Daniel Sauter; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2019-06-04       Impact factor: 21.023

Review 4.  HIV-1 Infection and Type 1 Interferon: Navigating Through Uncertain Waters.

Authors:  Sho Sugawara; David L Thomas; Ashwin Balagopal
Journal:  AIDS Res Hum Retroviruses       Date:  2018-08-15       Impact factor: 2.205

5.  HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes.

Authors:  Lia Vassena; Erica Giuliani; Herwig Koppensteiner; Sebastian Bolduan; Michael Schindler; Margherita Doria
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

6.  HIV Blocks Interferon Induction in Human Dendritic Cells and Macrophages by Dysregulation of TBK1.

Authors:  Andrew N Harman; Najla Nasr; Alexandra Feetham; Ani Galoyan; Abdullateef A Alshehri; Dharshini Rambukwelle; Rachel A Botting; Bonnie M Hiener; Eve Diefenbach; Russell J Diefenbach; Min Kim; Ashley Mansell; Anthony L Cunningham
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

7.  HIV-1 Vpu accessory protein induces caspase-mediated cleavage of IRF3 transcription factor.

Authors:  Sang Yoon Park; Abdul A Waheed; Zai-Rong Zhang; Eric O Freed; Juan S Bonifacino
Journal:  J Biol Chem       Date:  2014-10-28       Impact factor: 5.157

Review 8.  Innate antiviral immune signaling, viral evasion and modulation by HIV-1.

Authors:  Arjun Rustagi; Michael Gale
Journal:  J Mol Biol       Date:  2013-12-08       Impact factor: 5.469

Review 9.  Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis.

Authors:  Yun Zhou; Ying Zhang; Jonathan P Moorman; Zhi Q Yao; Zhan S Jia
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

10.  Innate DNA sensing is impaired in HIV patients and IFI16 expression correlates with chronic immune activation.

Authors:  S K Nissen; J F Højen; K L D Andersen; E Kofod-Olsen; R K Berg; S R Paludan; L Østergaard; M R Jakobsen; M Tolstrup; T H Mogensen
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.